Opioids for Chronic Pain in 2023
Lynn R. Webster, MD
Lynn R. Webster, MD
Learning Objectives
(1) Identify the unmet need and disease burden associated with pain conditions.
(2) Recognize patients that qualify for therapy to expand management capabilities.
(3) Address the barriers to adequate pain care.
(4) Consider risk versus benefits of opioid treatment on an individual basis.
(1) Identify the unmet need and disease burden associated with pain conditions.
(2) Recognize patients that qualify for therapy to expand management capabilities.
(3) Address the barriers to adequate pain care.
(4) Consider risk versus benefits of opioid treatment on an individual basis.
To receive CME/CE credit you must fill out the CME evaluation below!
Other Resources
Target Audience: Physicians, Nurse Practitioners, Physician Assistants, Nurses, Medical Technicians, Pharmacists, Psychologists, Physical Therapists and other healthcare professionals that treat pain conditions.
ACCREDITATION/DESIGNATION STATEMENTS
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network (PCN) and the American Chronic Pain Association (ACPA). Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.
Primary Care Network designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associates/Physician Assistants
PAs may claim a maximum of 0.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners/Nurses
The American Academy of Nurse Practitioners Certification Board (AANPCB) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Other Healthcare Professionals
All other healthcare professionals will receive a certificate of participation.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This activity is supported by educational grants from Averitas Pharma, Inc., Collegium Pharmaceutical Inc., and Salix Pharmaceuticals.
ACTIVITY OVERVIEW – This activity on Opioids for Chronic Pain was captured at the ACPA Inspire Pain Freedom CME Conference. This 30-minute presentation will identify the unmet need and disease burden associated with pain conditions. The presentation will help you recognize patients that qualify for therapy to expand management capabilities and address the barriers to adequate pain care. Lastly, it will help you consider risk versus benefits of opioid treatment on an individual basis.
FACULTY/CONTENT DEVELOPER
Lynn R. Webster, MD
Exec VP Scientific Affairs
Dr. Vince Clinical Research
Salt Lake City, Utah
Senior Fellow
Center for U.S. Policy, Washington, DC
Chief Medical Officer
PainScripts
FACULTY/PLANNING COMMITTEE DISCLOSURES
All relevant financial relationships have been mitigated for this activity.
Lynn Webster, MD – Faculty, Content Developer
Advisory Board: Ensysce Biosciences, AdhereRx (relationship has ended), Kempharm (relationship has ended)
Consultant: CognifiSense, Elysium Health, Ensysce Biosciences, Quivive Pharma
Research Grants: CognifiSense, Elysium Health
The individuals below have had no relevant relationships within the past 24 months:
Kathy Sapp – Program Planner
Chief Executive Officer, ACPA
Scott Farmer, MBA – Program Planner
Chief Operating Officer, ACPA
Brian Koffman, MD – PCN CME Reviewer
Chief Medical Officer, CLL Society
Jill Hays, CHCP – PCN CME Reviewer
Executive Director, Primary Care Network
Cindy Fisher – PCN CME Reviewer
CME Program Manager, Primary Care Network
RELEASE/EXPIRATION DATE
This internet, enduring activity will be available for one year, beginning December 1, 2023 through December 1, 2024.
UNLABELED USE DECLARATION
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
DISCLAIMER
The opinions, ideas, recommendations, and perspectives expressed during this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards and consultants, or the activity's commercial supporter(s), if applicable.
CONTACT INFORMATION – For questions about this activity please email us at [email protected] and place Opioid Program in the subject line.
ACCREDITATION/DESIGNATION STATEMENTS
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network (PCN) and the American Chronic Pain Association (ACPA). Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.
Primary Care Network designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associates/Physician Assistants
PAs may claim a maximum of 0.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners/Nurses
The American Academy of Nurse Practitioners Certification Board (AANPCB) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Other Healthcare Professionals
All other healthcare professionals will receive a certificate of participation.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This activity is supported by educational grants from Averitas Pharma, Inc., Collegium Pharmaceutical Inc., and Salix Pharmaceuticals.
ACTIVITY OVERVIEW – This activity on Opioids for Chronic Pain was captured at the ACPA Inspire Pain Freedom CME Conference. This 30-minute presentation will identify the unmet need and disease burden associated with pain conditions. The presentation will help you recognize patients that qualify for therapy to expand management capabilities and address the barriers to adequate pain care. Lastly, it will help you consider risk versus benefits of opioid treatment on an individual basis.
FACULTY/CONTENT DEVELOPER
Lynn R. Webster, MD
Exec VP Scientific Affairs
Dr. Vince Clinical Research
Salt Lake City, Utah
Senior Fellow
Center for U.S. Policy, Washington, DC
Chief Medical Officer
PainScripts
FACULTY/PLANNING COMMITTEE DISCLOSURES
All relevant financial relationships have been mitigated for this activity.
Lynn Webster, MD – Faculty, Content Developer
Advisory Board: Ensysce Biosciences, AdhereRx (relationship has ended), Kempharm (relationship has ended)
Consultant: CognifiSense, Elysium Health, Ensysce Biosciences, Quivive Pharma
Research Grants: CognifiSense, Elysium Health
The individuals below have had no relevant relationships within the past 24 months:
Kathy Sapp – Program Planner
Chief Executive Officer, ACPA
Scott Farmer, MBA – Program Planner
Chief Operating Officer, ACPA
Brian Koffman, MD – PCN CME Reviewer
Chief Medical Officer, CLL Society
Jill Hays, CHCP – PCN CME Reviewer
Executive Director, Primary Care Network
Cindy Fisher – PCN CME Reviewer
CME Program Manager, Primary Care Network
RELEASE/EXPIRATION DATE
This internet, enduring activity will be available for one year, beginning December 1, 2023 through December 1, 2024.
UNLABELED USE DECLARATION
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
DISCLAIMER
The opinions, ideas, recommendations, and perspectives expressed during this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards and consultants, or the activity's commercial supporter(s), if applicable.
CONTACT INFORMATION – For questions about this activity please email us at [email protected] and place Opioid Program in the subject line.